Back to search
Primary T-cell Immunodeficiency Disorders
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Primary T-cell Immunodeficiency Disorders trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which Primary T-cell Immunodeficiency Disorders trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
This is a Phase I/II non-randomized clinical trial of ex vivo hematopoietic stem cell (HSC) gene transfer treatment for X-linked severe combined immunodeficienc…
This study will determine the biochemical and genetic causes of inherited immune diseases affecting lymphocyte homeostasis. Lymphocytes are a type of white bloo…
Background: Allogeneic blood or marrow transplant is when stem cells are taken from one person s blood or bone marrow and given to another person. Researchers…
Background: Primary immunodeficiency disorders, or PIDs, are diseases that weaken the immune system. This makes it easier for a person to get sick. Some PIDs a…
Background: During a transplant, blood stem cells from one person are given to someone else. The cells grow into the different cells that make up the immune sy…
The major morbidities of allogeneic hematopoietic stem cell transplant (HSCT) using donors that are not human leukocyte antigen (HLA) matched siblings are graft…
This phase II trial investigates how well a naive T cell depleted graft work for the reduction of graft versus host disease in patients with non-malignant disea…
The purpose of this study is to assess the efficacy and safety of tabelecleucel in participants with EBV-associated diseases.